MedTrace Logo

An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in Lusaka

NCT04838587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6828

Last updated 2022-07-20

No results posted yet for this study

Summary

Diarrhoea is the one of the top five leading causes of death among children below the age of five years, globally. It is estimated that one in ten deaths in children under five is attributed to diarrhoea. Enterotoxigenic E.coli (ETEC) is one of the major causative agents of moderate-to-severe (MSD) diarrhoea among children both globally and in Zambia.

The overall aim of this study is to document the burden of ETEC associated diarrhoea in Zambian children under 3 years of age.

Conditions

  • Diarrhea Toddlers
  • Escherichia Coli Diarrhea

Interventions

OTHER

No intervention will be done

No intervention,Only passive surveillance of Diarrhoea cases will be done

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • Scandinavian Biopharma AB

    collaborator INDUSTRY

  • Göteborg University

    collaborator OTHER

  • Centre for Infectious Disease Research in Zambia

    lead OTHER

Principal Investigators

  • Roma Chilengi, MBChB · Centre for Infectious Disease Research in Zambia

  • Monde Muyoyeta, MBChB · Centre for Infectious Disease Research in Zambia

Eligibility

Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-10-15
Completion
2021-10-15

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04838587 on ClinicalTrials.gov